You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RLAY Sale Disclosure
Catinazzo Thomas · SEC Form 4 · Filed Jul 30, 2026
Sale
Calculated transaction value
$27.15K
Catinazzo Thomas Chief Financial Officer
RLAY
Relay Therapeutics
RLAY
Transaction date
Jul 28, 2026
Public filing date
Jul 30, 2026
Filing lag
Filed 2 days later
RLAY daily price context
Close on/before transaction
$18.29
Jul 28, 2026
First close after public filing
$18.83
Jul 31, 2026
30-day return after filing
-2.39%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,459 shares @ $18.61
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-326144
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$27.15K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relay Therapeutics, Inc. RLAY Current | Sale | Jul 28, 2026 | $27.15K |